Harvard Apparatus Regenerative Technology (Now Biostage, Inc.)

Harvard Apparatus Regenerative Technology (Now Biostage, Inc.) company information, Employees & Contact Information

Harvard Apparatus Regenerative Technology (NASDAQ: HART) makes bioengineered organ implants for life-threatening conditions. Our technology platform is to be used to restore function in the esophagus and the airways (trachea and bronchus). HART is completing further large-animal studies to refine our technology platform with the goal of filing an Investigational New Drug (IND) application with the U.S. Food and Drug Administration in 2016, seeking to initiate clinical trials for one of our three product candidates. Our first-generation trachea technology was used in five adult human trachea transplants approved under compassionate use exemptions, but none of our products are yet approved for marketing by a government regulatory authority.
Looking for a particular Harvard Apparatus Regenerative Technology (Now Biostage, Inc.) employee's phone or email?

Harvard Apparatus Regenerative Technology (Now Biostage, Inc.) Questions

Free Chrome Extension

Find emails, phones & company data instantly

Find verified emails from LinkedIn profiles
Get direct phone numbers & mobile contacts
Access company data & employee information
Works directly on LinkedIn - no copy/paste needed
Get Chrome Extension - Free

Aero Online

Your AI prospecting assistant